Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer. [electronic resource]
Producer: 20110609Description: 845-51 p. digitalISSN:- 1349-7006
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Asian People
- Biomarkers, Tumor -- analysis
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Remission Induction
- Survival Rate
- Tissue Distribution
- Treatment Outcome
- Xanthones -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.